Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 40 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
391 19.4 months Stage IIIA NSCLC 5 Chemotherapy
Surgery
University of Rochester Medical Center United States 10/2002
Treatment Details: Patients & Treatment: This Phase III study involved a total of 73 patients with stage IIIA non-small-cell lung cancer. Patients were divided into 5 groups. Group 1 (7 patients) received th
 
392 19.3 months Metastatic colorectal cancer 4 Chemotherapy
Aichi Cancer Center Hospital Japan 9/2010
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer. The patients were divided into 2 treatment groups. Group 1 included 213 patients with a median age of 63 years an
 
393 19.3 months Melanoma 4 Biologic therapy
Moffitt Cancer Center United States 9/2009
Treatment Details: Patients: This phase 2 study involved patients with advanced melanoma. Patients were divided into two separate treatments groups. Group A consisted of 58 patients with a median age of 58
 
394 19.3 months GBM or gliosarcoma 4 Biologic therapy
Chemotherapy
Radiation
University of California, San Francisco, Comprehensive Cancer Center United States 2/2009
Treatment Details: Patients: This study involved 65 glioblastoma multiforme or gliosarcoma patients with a median age of 55 years (range of 22-77). The percentages of male and female patients were not given.
 
395 19.3 months Hormone-refractory prostate cancer 5 Biologic therapy
Chemotherapy
Institut Jean-Godinot France 6/2007
Treatment Details: Patients: This phase II study involved 92 patients with advanced hormone-refractory prostate cancer. The men had received a hormone-based therapy before entering this study, but had no pri
 
396 19.2 months Advanced hormone refractory prostate cancer 5 Biologic therapy
Chemotherapy
Hospital Universitari del Mar Spain 11/2007
Treatment Details: Patients: This phase II study involved 48 men with advanced hormone-refractory prostate cancer. The median age was 67 years, ranging from 48-78. All had received prior hormone therapy, 54
 
397 19.2 months Advanced hormone refractory prostate cancer 4 Chemotherapy
Immunotherapy
Division of Medical Oncology, Azienda Italy 12/2007
Treatment Details: Patients: This phase II study involved 40 men with hormone refractory prostate cancer. The median age was 72, ranging from 55-83 years old. Treatment: These patients were treated with
 
398 19.2 months Metastatic colorectal cancer 4 Chemotherapy
Hospital General Universitario Gregorio Marañón Spain 10/2009
Treatment Details: Patients: This study involved 53 patients with metastatic colorectal cancer. The majority (39) were men. The median age was 66, ranging from 42 to 80 years of age. Treatment: Patients
 
399 19.2 months Advanced hepatocellular carcinoma 4 Biologic therapy
The University of Texas M.D. Anderson Cancer Center United States 12/2008
Treatment Details: Patients: This study involved twenty-eight patients with advanced hepatocellular carcinoma. Eighteen of the patients were men. These patients ranged in age from 30 to 85 years old, and th
 
400 19.2 months metastatic melanoma Immunotherapy
Istituto Nazionale per lo Studio e la Cura dei Tumori Italy 10/2005
Treatment Details: Patients: This Phase II study involved 38 pretreated metastatic melanoma patients, of which 20 received at least one or two complete cycles of treatment. Treatment: The treatment consist
 
Page 40 of 187  | Previous Page  | Next Page